Private drug developer Servier Group said on Sunday its experimental brain cancer treatment has considerably slowed the progession of a type of brain tumor, a positive in a field that has not seen progress for more than 20 years.
The drug, vorasidenib, delayed the growth of grade 2 glioma for a median of 27.7 months, more than twice compared to 11.1 months for patients who received a placebo.
Grade 2 gliomas are progressive, malignant brain tumors, which are more common in adults but can also occur in children and teenagers. The study, involving 331 patients who had undergone no previous treatment other than surgery, showed that vorasidenib significantly improved progression-free survival and delayed the time before moving to further anticancer intervention like chemotherapy and radiation, according to results that have also been published in the New England Journal of Medicine.
Vorasidenib was granted fast track designation by the U.S. Food & Drug Administration in March 2023 and the company is currently working on timelines for submission of a New Drug Application for vorasidenib to the FDA.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Treatment Breakthrough for an Intractable Brain CancerA new drug helped stall brain-cancer growth in a study of glioma patients, a breakthrough in a field that has made little progress in decades
Read more »
Oral Drug for Brain Tumor Could Change Treatment LandscapeIn patients with gliomas bearing IDH1/2 mutations, the brain barrier-crossing oral drug vorasidenib kept tumors at bay, and could be used instead of more toxic chemotherapies and radiation. ASCO23
Read more »
Nick Cannon says Jamie Foxx remains private about health, will speak 'when he's ready'Nick Cannon shared how Jamie Foxx turned down his offer to be 'a mouthpiece' after Foxx's health scare: “When he's ready, he's going to address ... the world.'
Read more »
Euclid man found hiding in basement sentenced for drug, firearm possessionA Euclid man was found guilty on all charges related to drug and firearm possession Tuesday.
Read more »
FDA allows temporary import of unapproved Chinese cancer drug to ease U.S. shortageThe FDA has given Qilu Pharmaceutical permission to ship cisplatin to the U.S. to ease a national cancer drug shortage.
Read more »